Sp1210

NEUROIMMUNE INTERACTIONS INVOLVED IN VISCERAL PAIN

Date
May 9, 2023
Explore related products in the following collection:

Society: AGA

Abdominal pain is one of the most common reasons for doctors visits, and presents in numerous GI diseases. Unfortunately the current treatment options targeting sensory neurons to reduce pain have limited efficacy or unwanted side effects, and this is especially true for visceral pain. Recent evidence strongly suggests that non-neuronal cell populations found in the gut, including epithelial cells, enteric glia, immune cells and gut microbiota, play major roles in visceral pain by directly interacting with sensory neurons that carry pain information. In this session, you will learn about how these 'unusual suspects' (i.e., non-neuronal cell types) are involved in visceral pain processes and and how manipulating their activity reduces hypersensitivity, inflammation, and other GI disease outcomes.

Presenter

Speaker Image for Giovanni Barbara
University of Bologna, Italy

Tracks

Related Products

Thumbnail for INTRODUCTION
INTRODUCTION
SOCIETY: AGA
Thumbnail for AGA-Rome Foundation Lectureship: Do Changes in Intestinal Permeability Translate into Clinical Symptoms and Treatments in Disorders of Gut-Brain Interaction?
AGA-Rome Foundation Lectureship: Do Changes in Intestinal Permeability Translate into Clinical Symptoms and Treatments in Disorders of Gut-Brain Interaction?
Disorders of gut-brain interaction (DGBI), including irritable bowel syndrome (IBS) and functional dyspepsia (FD), are among the most common gastrointestinal (GI) disorders seen in primary care and GI practices. The pathophysiology is multifactorial and not well understood…
Thumbnail for AGA Peripheral vs. Central Mechanisms in Symptom Generation in Disorders of Gut-Brain Interaction (DGBI)
AGA Peripheral vs. Central Mechanisms in Symptom Generation in Disorders of Gut-Brain Interaction (DGBI)
A session focusing on recent advances in our understanding of the complex pathophysiology of disorders of gut-brain interaction (DGBI)…
Thumbnail for HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…